1. Home
  2. Live Updates
  3. Vera Therapeutics (VERA) Presents Positive 72-Week Data Show

Vera Therapeutics (VERA) Presents Positive 72-Week Data Show

Vera Therapeutics (VERA) Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy

Vera Therapeutics (VERA) Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

New York , United States , Richard Lafayette , Marshall Fordyce , Vera Therapeutics Inc , Nasdaq , Vera Therapeutics , Stanford Glomerular Disease Center , Stanford University Medical , Chief Executive Officer , Data From , Are Consistent With , True Disease Modification ,